The United Laboratories International Holdings Limited (United Lab) was establishedin Hong Kong in 1990, and listed on Hong Kong Exchange (stock code: 03933.HK) in June 2007. Through over 20 years of development, the United Lab now has six production sites, including The United Laboratories Co., Ltd.,Zhuhai United Laboratories Co., Ltd., Zhuhai United Laboratories(Zhongshan) Co., Guangdong Kaiping Kingly Capsule Co., Ltd., The United Laboratories(Inner Mongolia) Co., Ltd. and The United Animal Healthcare (Inner Mongolia)Co., Ltd. With an advanced chemical drug and biological product R&D center, a complete professionalmarketing team and around 12,000 employees in total, it has developed into a comprehensive pharmaceutical group engaged with the R&D, production and operation of medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations.
All workshops of United Lab have passed the new-version Chinese GMP certification; dozensof its products received the European Union GMP certificates (such as Germany, Romania, etc.) and US FDA certificate. By virtue of its advanced enzymatic Amoxicillin manufacturing process, TUL is the first Chinese enterprise to be certified CEP by EDQM on enzymatic Amoxicillin, and many of its scientific and technological achievements obtained the national patent.
United Lab now has 11 series of preparation products consisting of over 60 varieties with more than 120 specifications available. Besides, it also possesses 5 series of API products with nearly 50 varieties. Among its products, Amoxicillin Capsules, Ampicillin Capsules, Amoxicillin Granules, Potassium Guaiacolsulfonate and Codeine Phosphate Oral Solution, and Compound Codeine Phosphate Oral Solution are called the "Three Panaceas and Two Solutions" in the industry; the "USLINR" series recombinant human insulin products advantages are high purity, good safety and stable quality; the USLENR series insulin glargine products employ advanced purification technology and production equipment, meeting the quality standards of United States Pharmacopeia in all aspects. Meanwhile, United Lab is also the first enterprise attaining the approval for the production of memantine hydrochloride series productsin China.
United Labowns advanced production equipment and adequate production capacity. Every year, it can produce 1.8 billion capsules, 1 billion tablets, 134 million sachets of granules, 86 million sachets of suspension, 20 million vials of oral solution, 117 million vials of powder injections, 37.8 million tubes of ointments, 28 million vials of lyophilized powder for injection, 24 million tubes of eye drops and about 300 million tubes of insulin preparation.
United Lab lays equal stress on development and environmental protection and takes the path of sustainable development. It has invested nearly RMB 2 billionto environmental treatment and spares no effort to achieve green productivity by introducing internationally-advanced technology and equipment and staffing itself with professional teams. For the endeavors in the utilization of high and new technology, environmental protection and energy conservation, the company received many honored titles such as the "Excellent Innovative Enterprise of Guangzhou Province", the "Enterprise of Environmental and Social Responsibilities", etc.
Since 1998, United Lab has donated nearly RMB100 millionto over 30 programs in suchfieldsas education, disaster relief, social welfare, etc., and organized for many times its staff to participate in voluntary blood donation, social work, charity and other public benefit activities, fulfilling its responsibilities and missions as a modern enterprise.
United Lab will consistently adhere to its commitment to "Making Life More Valuable", dedicate itself to the development of Chinese medical health undertakings and provide the society with more high-quality and high-efficient medical products.